Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
48 hedge funds and large institutions have $145M invested in Alpine Immune Sciences Inc in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
9% more funds holding
Funds holding: 44 → 48 (+4)
10% less capital invested
Capital invested by funds: $160M → $145M (-$15.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.74M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.39M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$3.28M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.05M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$4.64M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.52M |
| 3 |
CCM
CAAS Capital Management
New York
|
-$1.87M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$797K |
| 5 |
Renaissance Technologies
New York
|
-$772K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
6CM
51
683 Capital Management
New York
| – | -$296K | -23,493 | Closed |
|
52
JP Morgan Chase
New York
| – | -$73K | -5,830 | Closed |
|
53
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$3K | -236 | Closed |
|
|
SFS
54
Sowell Financial Services
North Little Rock,
Arkansas
| – | +$125 | +10 | New |
|
ALPN Hedge Fund Activity: Q1 2021 in Review
48 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q1 2021, worth a combined $145M — down 9.6% from $160M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ALPN positions and 7 closed out — a net gain of 4 holders — while 15 added to existing stakes and 10 trimmed.
The largest buyer was Ikarian Capital, adding an estimated $3.74M. The largest seller was Morgan Stanley, cutting an estimated $4.64M.
- 48 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q1 2021, up from 44 in Q4 2020.
- Funds reported $145M of Alpine Immune Sciences Inc stock for Q1 2021, down 9.6% quarter-over-quarter.
- 11 funds opened new Alpine Immune Sciences Inc positions in Q1 2021 and 7 closed out, a net change of +4 holders.
- The largest Alpine Immune Sciences Inc buyer in Q1 2021 was Ikarian Capital, an estimated $3.74M added.
- The largest Alpine Immune Sciences Inc seller in Q1 2021 was Morgan Stanley, an estimated $4.64M sold.
Based on aggregated 13F filings for Q1 2021.